Bempeget-EZ™

Therapeutic Segment:

Cardiometabolic

Generic Name:

Bempedoic Acid + Ezetimibe

Indication

Tablets
  • 180mg + 10mg

Bempeget-EZ Tablet is indicated in adults with primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia, as an adjunct to diet:

  • In combination with a statin in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin, in addition to Ezetimibe.
  • Alone in patients who are either statin-intolerant or for whom a statin is contraindicated, and are unable to reach LDL-C goals with Ezetimibe alone.
  • In patients already being treated with the combination of Bempedoic Acid and Ezetimibe as separate tablets with or without statin.